News

From 1 January 2025, new rules on the labelling and packaging of medicines will come into effect across the United Kingdom, including Northern Ireland, under the Windsor Framework. These rules will prohibit prescription medicines in Northern Ireland from being labelled with European Union (EU) safety features. The requirements of the EU Falsified Medicines Directive (FMD) for medicines marketed and supplied in Northern Ireland will no longer apply.

LZVO provides guidance on the actions to be taken by the end user when the system displays an NMVS_NC_PC_01 (Unknown product) error notification with the package status "UNKNOWN" during the verification process of a medicine package, but no alert is generated.

Italy and Greece are the two countries that were granted the longest transition period of 6 years for the implementation of the Falsified Medicines Directive. Accordingly, from February 9, 2025, the European Medicines Verification System must also be operational in these countries, where active preparations are currently underway.

2024. gada pirmajā pusgadā Latvijas aptiekas un ārstniecības iestādes pret viltojumiem ir pārbaudījušas 15 miljonus zāļu iepakojumu, rūpējoties, lai pie pacientiem nonāk tikai drošas un autentiskas zāles.

Study supporting the report on trends in the falsification of medicinal products and measures provided according to Directive 2011/62/EU.

LZVO (Latvijas Zāļu verifikācijas organizācija) releases newsletter No. 10.